The HIP Self-management Study

Study acronym: HIPS
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Jul 2026 → Oct 2026
See other at-risk trials from Oslo University Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 2026 to Oct 2026
    • Eligibility criteria expanded, about 20 words
    • Secondary endpoints: details revised at 8 of 11 entries
    • Publications: details revised at 1 of 1 entry
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Jul 1, 2026 to Jul 2026
    • Study completion date: Jun 30, 2027 to Oct 2026
    • Site details revised
    v6
  3. Study completion date: Jan 1, 2027 to Jun 30, 2027
    • Eligibility criteria shortened, about 17 words
    v5
  4. Secondary endpoints: 10 to 11v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  6. Secondary endpoints: details revised at 4 of 10 entries
    • Study description shortened, about 6 words
    v2
  7. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The HIPS-study will be an observer blinded, single-centre, parallel-group randomized controlled trial (RCT). The main purpose of the study is: 1. To investigate the clinical effectiveness of a self- management program versus usual care for patients with greater trochanteric pain syndrome (GTPS). * H0: There is no difference between a self-management program and usual care on pain and function in patients with GTPS. * H1: There is a difference between a self-management program and usual care on pain and function in patients with GTPS. 2. To investigate if self-management is more cost-effective than usual care in the treatment of patients with GTPS. Participants will be randomly allocated into one of two groups: 1) self-management program or 2) usual care. Follow-up will be at 3-, 6- and 12-months.
Trial Details
NCT Number NCT06297148
Lead Sponsor Oslo University Hospital
Collaborators: Oslo Metropolitan University, Fysiofondet, University of Oslo
Conditions
(from sponsor)		 GTPS - Greater Trochanteric Pain Syndrome, Gluteal Tendinopathy, Trochanteric Bursitis, Lateral Hip Pain
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov